32 results
424B5
SEEL
Seelos Therapeutics Inc
30 Jan 24
Prospectus supplement for primary offering
6:05am
pandemic;
sales of our common stock by us or our stockholders in the future; and
the trading volume of our common stock.
In addition, the stock
424B5
SEEL
Seelos Therapeutics Inc
30 Nov 23
Prospectus supplement for primary offering
4:58pm
potential recession or economic downturn;
public health crises, pandemics, and epidemics, such as the COVID-19 pandemic;
sales of our common stock by us … of the coronavirus (“COVID-19”) pandemic on our business, financial condition and operations. COVID-19 infections have been reported throughout the United
424B5
SEEL
Seelos Therapeutics Inc
28 Nov 23
Prospectus supplement for primary offering
4:06pm
. equity market, including any potential recession or economic downturn;
public health crises, pandemics, and epidemics, such as the COVID-19 pandemic … of the coronavirus (“COVID-19”) pandemic on our business, financial condition and operations. COVID-19 infections have been reported throughout the United States
424B5
w0v1ou1 r9cnb0r
25 Sep 23
Prospectus supplement for primary offering
6:02am
424B5
kcf4zkqbbp4yrieogr
12 May 22
Prospectus supplement for primary offering
8:30am
424B3
8otqfiha
27 Dec 21
Prospectus supplement
5:01pm
424B5
6beb10ush7dml6qw2 0y
21 May 21
Prospectus supplement for primary offering
12:00am
424B5
pesryqjz
19 May 21
Prospectus supplement for primary offering
4:08pm